VANI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VANI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the three months ended in Dec. 2024, Vivani Medical received $4.97 Mil more from issuing new shares than it paid to buy back shares. It received $0.05 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It spent $0.19 Mil on other financial activities. In all, Vivani Medical earned $4.83 Mil on financial activities for the three months ended in Dec. 2024.
The historical data trend for Vivani Medical's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivani Medical Annual Data | |||||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||
Cash Flow from Financing | 9.19 | 11.62 | 63.39 | 0.13 | 19.05 |
Vivani Medical Quarterly Data | ||||||||||||||||
Dec20 | Mar21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Cash Flow from Financing | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.02 | 13.69 | 0.11 | 0.43 | 4.83 |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Vivani Medical's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:
Cash Flow from Financing | (A: Dec. 2024 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 18.817 | + | 0 | + | 0.426 | + | 0 | + | 0 | + | -0.189 |
= | 19.05 |
Vivani Medical's Cash from Financing for the quarter that ended in Dec. 2024 is:
Cash Flow from Financing | (Q: Dec. 2024 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 4.97 | + | 0 | + | 0.047 | + | 0 | + | 0 | + | -0.189 |
= | 4.83 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $19.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivani Medical (NAS:VANI) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Vivani Medical's issuance of stock for the three months ended in Dec. 2024 was $4.97 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Vivani Medical's repurchase of stock for the three months ended in Dec. 2024 was $0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Vivani Medical's net issuance of debt for the three months ended in Dec. 2024 was $0.05 Mil. Vivani Medical received $0.05 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Vivani Medical's net issuance of preferred for the three months ended in Dec. 2024 was $0.00 Mil. Vivani Medical paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Vivani Medical's cash flow for dividends for the three months ended in Dec. 2024 was $0.00 Mil. Vivani Medical received $0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Vivani Medical's other financing for the three months ended in Dec. 2024 was $-0.19 Mil. Vivani Medical spent $0.19 Mil on other financial activities.
Thank you for viewing the detailed overview of Vivani Medical's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Gregg Williams | director, 10 percent owner | PO BOX 200, WALLED LAKE MI 48390-0200 |
Donald Dwyer | officer: Chief Business Officer | 54 CHERRY FARM LANE, WEST CHESTER PA 19382 |
Brigid Makes | officer: CFO | 20245 SW 95TH AVENUE, TUALATIN OR 97062 |
Aaron Mendelsohn | director | 224 15TH STREET, SANTA MONICA CA 90402 |
Joachim Eberhard Bolck | 10 percent owner | 33 CLUB VIEW LANE, ROLLING HILLS ESTATES CA 90274 |
Lisa Ellen Porter | officer: Chief Medical Officer | 778 CORDILLERAS AVE, SAN CARLOS CA 94070 |
Truc Le | officer: COO | 1905 WEST RED FOX ROAD, SANTA ANA CA 92704 |
Adam Mendelsohn | director, officer: CEO | C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608 |
Wilford Dean Baker | director | 200 FLYNN ROAD, CAMARILLO CA 93012-8790 |
Larson Alexandra L.p. | director | 3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302 |
Scott Dunbar | officer: Acting CEO | 13170 TELFAIR AVENUE, SYLMAR CA 91342 |
Edward Jonathon Sedo | officer: Controller | 4485 FORESTGLEN CT, MOORPARK CA 93021 |
Jessy Dana Dorn | officer: VP-Clin & Scientific Affairs | 12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342 |
Matthew J Pfeffer | director | |
Patrick Ryan | officer: Chief Operating Officer | C/O SECOND SIGHT MEDICAL PRODUCTS, INC., 12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR CA 91342 |
From GuruFocus
By GuruFocus News • 04-16-2025
By Business Wire • 08-13-2024
By Business Wire • 09-26-2024
By Business Wire • 09-23-2024
By Business Wire • 03-01-2024
By GuruFocus News • 04-15-2025
By Business Wire • 03-06-2024
By Marketwired • 03-27-2025
By Business Wire • 12-04-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.